Everything we covered on WTR over the past seven days, and all you need to know from the world of trademarks to set yourself up for the start of another busy week.

A group of lawmakers wants the U.S. Patent & Trademark Office and drug companies to change their approach toward handling ...

In the 24th year of the competition, Istanbul will stage its first-ever UEFA Women's Champions League tie this week as ...

During an investor presentation Thursday, executives admitted to being overly optimistic their vaccine could wrest significant market share away from GSK's and Pfizer's products this year.

CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza ... regulations and governmental policies, pressures from increasing competition and consolidation in the company’s industry ...

GameStop announced an offering of up to 20 million shares. In Q2, GameStop reported revenue of $798.3 million, compared to $1 ...

GSK’s GSK phase III study evaluating its blockbuster drug Nucala (mepolizumab), an anti-IL5 biologic, for treating chronic ...

GSK’s twice-yearly depemokimab reduced asthma attacks by half and cut clinic visits by nearly three-quarters, positioning it ...

Bispecific antibodies and anti-TIGIT therapies both appear to be writing comeback stories as cancer experts head to Barcelona for the 2024 European Society for Medical Oncology Congress. Radioligand ...

The revenue for GSK-3739937 is expected to reach an annual total of $7 ... You can make better informed decisions and gain a future-proof advantage over your competitors. Be better informed GlobalData ...

You can make better informed decisions and gain a future-proof advantage over your competitors. Be better informed GlobalData, the leading provider of industry intelligence, provided the underlying ...

Analyst Graham Parry from Bank of America Securities maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) and keeping the ...